[ARS] APTARGROUP, INC. SEC Filing

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

ARS

03/27/2026 - 08:15 AM

ARS - APTARGROUP, INC.

ARS Filing - APTARGROUP, INC.

This filing is available as a PDF document.

Filing Type: ARS

Company: APTARGROUP, INC. (ATR)

Acceptance Date: 2026-03-27T08:15:22.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Aptargroup

NYSE:ATR

View ATR Stock Overview →

ATR Rankings

#1061 Ranked by Market Cap

#1143 Ranked by Dividends

#1591 52-Week Gainer

#750 YTD Gainer

#1399 Ranked by Short %Change

ATR Latest News

Mar 19, 2026

Aptar’s Unidose Powder Nasal Delivery System Used in ENA Respiratory Phase II Clinical Study of Investigational INNA‑051 Nasal Spray

Mar 17, 2026

Aptar Announces Gael Touya as its Next Chief Executive Officer; Stephan B. Tanda to Retire by the End of the Year

Mar 16, 2026

Aptar’s Intranasal Delivery System Used in Phase II Clinical Study for Investigational SPONTAN® Nasal Spray

Feb 18, 2026

Aptar to Participate in Upcoming Investor Conferences

Feb 5, 2026

Aptar Reports Fourth Quarter and Annual 2025 Results

ATR Latest SEC Filings

Mar 27, 2026

[DEF 14A] APTARGROUP, INC. Definitive Proxy Statement

Mar 26, 2026

[SCHEDULE 13G/A] APTARGROUP, INC. Amended Passive Investment Disclosure

Mar 20, 2026

[Form 4] APTARGROUP, INC. Insider Trading Activity

Mar 20, 2026

[Form 4] APTARGROUP, INC. Insider Trading Activity

Mar 18, 2026

[Form 4] APTARGROUP, INC. Insider Trading Activity

ATR Stock Data

Market Cap 7.87B

Float 63.60M

Industry Medical Instruments & Supplies

Sector Plastics Products, Nec

Website Link

Country United States

City CRYSTAL LAKE